Introduction: Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease characterized by the scarring of lung tissue. It affects primarily older adults and its cause remains unknown, hence the term “idiopathic.” Over the years, the treatment landscape for IPF has evolved significantly, with researchers and pharmaceutical companies striving to develop novel therapeutics to improve […]
Tag: Idiopathic Pulmonary Fibrosis Treatment Market
Back To Top